Phenagil Tablet
Product Images NDC 58552-322

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Phenagil (NDC 58552-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gil Pharmaceutical Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

4131-label (4131 Label)

4131-label (4131 Label)
The text provides drug facts and directions for using a medication that treats allergy symptoms, including runny nose, sneezing, itchy and watery eyes, nasal and sinus congestion. The product contains Chlorpheniramine and Phenylephrine HCI and may cause excitability in children and drowsiness. People using the product are advised to avoid alcohol, sedatives, and tranquilizers and use caution while driving or operating machinery. The text includes warnings for people with health conditions such as heart disease, high blood pressure, and thyroid disease. If the given symptoms do not improve within seven days and occur with a fever, the user should consult a doctor. The medication is manufactured by GIL PHARMACEUTICAL CORP in Ponce, Puerto Rico.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.